Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia

Class:IdLiteratureReference:9965469
_displayNameNovel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
_timestamp2025-08-29 18:58:23
author[Person:5173300] Li, Wei
[Person:9965464] Ji, Min
[Person:6788829] Lu, Fei
[Person:9965462] Pang, Yihua
[Person:9929989] Dong, Xin
[Person:9965465] Zhang, Jingru
[Person:571189] Li, Peng
[Person:6800626] Ye, Jingjing
[Person:9965467] Zang, Shaolei
[Person:9965466] Ma, Daoxin
[Person:9965449] Ji, Chunyan
created[InstanceEdit:9965463] Orlic-Milacic, Marija, 2025-08-29
journalCell Death Dis
pages855
pubMedIdentifier30154435
titleNovel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
volume9
year2018
(literatureReference)[Reaction:9965437] The complex of MLLT11 and TCF7 binds CD44 gene promoter [Homo sapiens]
[Summation:9965470] MLLT11 (AF1Q) enhances the binding affinity of the CTNNB1:TC...
[Summation:9965489]

MLLT11 (AF1Q), which forms a complex with TCF7 and CTNNB1...

[Change default viewing format]
No pathways have been reviewed or authored by Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia (9965469)